Colleen Santoro

Principal Scientist Merck & Co

Colleen Santoro is a CMC Potency professional who has spent over 15 years in the discipline at Bristol-Myers Squibb and MSD.

Seminars

Monday 8th March 2027
Unleashing Comprehensive Potency Strategies for Complex ADCs
11:30 am
  • Executing phase-appropriate ADC potency strategies that address regulatory expectations for all stages of product development and meet desirable performance criteria
  • Determining the role of potency assays in characterising inherent properties of ADCs
  • Presenting case studies that demonstrate mechanism of action-driven method development for complex ADCs
Colleen Santoro - Merck